The rate on the quote is the least useful number when you’re trying to find the best high risk payment processors for a peptide brand. What actually separates them is who the acquiring bank is, how the reserve works, what it costs to leave, and whether the account survives your first bad month.
We’ve sat through a lot of these sales calls on behalf of peptide merchants. The providers sound alike for the first ten minutes. They stop sounding alike once you ask the questions below, in writing, and compare the answers line by line.
This post assumes you already know what a high-risk merchant account is and what goes into the application. If you don’t, start with our guide to how a high risk merchant account works for peptide stores.
Who are you actually signing with?
“Processor” gets used for four very different businesses, and the difference matters more than any rate.
- Direct acquirer. The bank (or its processing arm) contracts with you directly. Fewer layers, and the people deciding your risk are the people you talk to.
- ISO. An independent sales organization sells and services accounts on behalf of a sponsor bank. Most high-risk accounts are sold this way. The ISO handles your onboarding and support; the bank still owns the decision.
- Payment facilitator (PayFac). You’re a sub-merchant under the PayFac’s master account, the way Stripe works. Visa’s acceptance risk standards say a PayFac with high-integrity-risk merchants “must be registered as a High-Risk Internet PayFac”.
- Broker or marketplace. Matches you to providers and takes a fee or commission. Useful for reach, but you still need to know where you end up.
Visa requires acquirers to register and oversee their ISOs and PayFacs “at least annually”, so the bank is always in the picture, even when you never speak to it. That’s why the first question on our list is always the same: which bank is the acquirer, and in which country?
It matters for redundancy too. Two accounts from two different ISOs that sit on the same sponsor bank are one decision away from both closing.
Where the bank is changes more than the rate
Some high-risk options for peptide merchants run through acquirers outside the merchant’s home country. That isn’t automatically a problem, but it changes the deal:
- Cross-border costs. When your customers’ cards are issued in one country and the acquirer sits in another, transactions typically carry extra network fees and can see more declines.
- Currency. Check what currency you’re settled in and who sets the conversion rate.
- Payout method and speed. One provider that advertises peptide accounts, Instabill, describes working “through an offshore banking partner” and paying merchants out in crypto or ACH. Know exactly how and when money reaches your operating account.
- Your reserve. Find out which entity holds it, in which jurisdiction, and what happens to it if the relationship ends.
Our view: an offshore account can be a reasonable part of a setup, but we wouldn’t make it the only account unless there’s genuinely no domestic option.
Reserve terms to compare
Two reserves with the same percentage can be very different deals. Compare these points:
- Type. Rolling (a slice of every settlement, released after the holding period), capped (rolling until a fixed amount is reached), or upfront (a lump sum before you go live).
- Percentage and holding period. Published ranges at the time of writing (late 2026) are typically 5 to 10% held for 90 to 180 days, with one peptide-focused source quoting 5 to 10% held for 120 to 180 days. Corepay describes 5 to 15% as typical “but they can be higher”.
- Review trigger. Can the reserve be reduced after six months of clean processing? Ask what numbers would get you there.
- Increase rights. Most agreements let the provider raise the reserve. Ask how much notice you get.
- On termination. How long they hold everything after the account closes, and how the release is calculated.
Rate structure: interchange-plus, tiered or flat
Interchange-plus passes through the card networks’ interchange and assessment costs and adds a fixed markup (for example a percentage plus a few cents). It’s the easiest to audit because you can see what the bank adds.
Tiered pricing sorts transactions into buckets such as qualified, mid-qualified and non-qualified, each with its own rate. It looks cheap on the quote because the quote shows the qualified rate, and online card-not-present orders often fall into the pricier tiers. It’s also hard to compare between providers.
Flat rate is one percentage for everything. Simple to budget, and common in high-risk. Binderr, a marketplace for high-risk merchants, quotes card rates for peptide models around 3.5 to 5%.
Then come the line items that never appear in the headline: per-transaction fees, gateway fees, monthly minimums, PCI fees, chargeback and retrieval fees, and network registration pass-throughs. Visa’s high-integrity-risk registration fee is $950. A processor summary reports Mastercard’s specialty registration rising to $1,000 per merchant per year from 1 May 2026, plus a new $0.02 per-transaction fee and a 10 bps volume fee from 3 June 2026, all billed to acquirers (not yet verified against a Mastercard bulletin). Ask each provider which of these they pass through and under what name.
The only fair comparison is an effective rate: take three months of your real orders, apply each provider’s full fee schedule, and divide total fees by total volume.
Contract length and early termination fees
High-risk agreements often run one to three years and renew automatically unless you give notice in a set window. Leaving early can cost a flat early termination fee, or “liquidated damages” calculated as your average monthly fees multiplied by the months remaining.
We’d push back hard on liquidated damages in a high-risk contract. Most agreements let the provider end the relationship quickly, so a clause that makes it expensive for you to leave is one-sided. Get the notice period, renewal date and exit cost written into your comparison.
Chargeback tools, settlement and gateway fit
Dispute tools. Ask which of these are available and how they’re priced: Verifi Order Insight and Rapid Dispute Resolution (RDR) for Visa, Ethoca Alerts for Mastercard, and support for Visa’s Compelling Evidence 3.0 on fraud disputes. RDR matters because disputes it resolves are excluded from Visa’s monitoring ratio. A provider that includes these and helps you configure them is worth a slightly higher rate.
Settlement. Daily or weekly payouts, how many days in arrears, and whether weekends and holidays slow things down. Cash flow is already tight under a reserve.
Gateway compatibility. Check there’s a maintained plugin or integration for your platform. On WooCommerce you have more choice of gateways. On Shopify, an outside processor has to integrate with Shopify, and Shopify adds its own fee on third-party gateway transactions: 2% on Basic, 1% on Grow, 0.6% on Advanced and 0.2% on Plus per its US pricing page at the time of writing. Also ask about 3-D Secure support and whether the gateway can route between more than one merchant account later.
Support. A named account manager, a direct line to the risk team, and a clear process for how you’ll be told about reserve changes or document requests. You’ll need these on the day something goes wrong.
Processors that advertise peptide accounts
A few high risk payment processing companies publicly advertise peptide accounts. Here’s what they say about themselves, neutrally and without endorsement:
- Corepay says “As of April 1, 2024, we are unable to assist peptide platforms that are not LegitScript certified” and “We do not support research-use-only (RUO) peptide sellers.”
- Easy Pay Direct says “you MUST be Legit Script certified to get a merchant account for Peptides” and offers a 50% LegitScript discount.
- Instabill describes peptide accounts “through an offshore banking partner”, including payment “by gift card”, with merchants paid out in crypto or ACH.
- Binderr, a marketplace, says “LegitScript certification is not required by the card networks” for peptide models, and expects a certificate of analysis for every product and no dosing or health claims.
These positions contradict each other, and that’s the useful lesson. LegitScript is a requirement some processors and their banks set, not a published card-network rule for peptides. And because LegitScript’s programs are aimed at healthcare merchants, a research-use-only store can’t assume it will qualify. Also watch for providers whose high-risk pages list “nutraceuticals” or “supplements”: that isn’t the same as accepting peptides. Get acceptance of your exact business model in writing.
A scorecard for picking the best high risk payment processors
Score each provider 1 to 5 on each row, multiply by the weight, and add it up. The weights are our judgment for a typical peptide store; adjust them to yours.
| Criterion | Question to ask | Good answer looks like | Weight |
|---|---|---|---|
| Acquiring bank | Which bank, in which country? | Named, and willing to put it in writing | 3 |
| Category acceptance | Do you accept my exact model (RUO or clinic)? | Yes, in writing, with requirements listed | 3 |
| Reserve | Type, %, hold, review trigger? | Rolling or capped, with a stated path to reduce it | 3 |
| Pricing | Full fee schedule, including pass-throughs? | Interchange-plus or flat, every line item named | 2 |
| Contract | Term, renewal, exit cost? | Short term or month-to-month, no liquidated damages | 2 |
| Dispute tools | RDR, Ethoca, CE 3.0 support? | Available, priced, and set up with you | 2 |
| Settlement | Payout frequency, currency, method? | Daily or near-daily, in your currency, to your bank | 2 |
| Gateway fit | Works with my platform and multiple MIDs? | Maintained integration, routing supported | 2 |
| Support | Who do I call when the risk team writes? | A named person and a stated response time | 1 |
A provider that scores well on rate and badly on the first three rows is a provider you’ll be replacing.
How we’d run the comparison
- Shortlist three providers that say, in writing, that they accept your exact business model.
- Send each one the same written question list (the scorecard’s second column).
- Ask for a full fee schedule and the draft merchant agreement before you submit an application.
- Calculate an effective rate on three months of your real orders.
- Score the answers, then read the termination and reserve clauses one more time.
- Apply to the top one or two only.
If you’d like someone who’s read a lot of these agreements to do the comparison with you, that’s part of our peptide payment processing work. We work with research suppliers who want to run a clean, defensible business and with clinics and telehealth brands that can qualify for certification, and we don’t help anyone dress up human-use sales as research.
Frequently asked questions
What’s the difference between a high risk payment processor and a high risk merchant account?
The merchant account is your MID with an acquiring bank. The processor is the company that sells, services or runs that account, which may be the bank itself, an ISO, a payment facilitator or a broker. When you compare processors, you’re really comparing the bank behind them and the terms they’ve negotiated.
Are offshore high risk processors a bad idea for peptide stores?
Not automatically, but they change the deal: cross-border fees, currency conversion, payout methods and where your reserve is held. We’d use one as part of a setup rather than the only account when a domestic option exists.
What’s a normal rate for high risk credit card processing?
For peptide merchants, one marketplace quotes card rates around 3.5 to 5% at the time of writing. The rate matters less than the full fee schedule and the reserve, so compare effective rates on your own order data.
Do all high risk payment processing companies require LegitScript for peptides?
No. Some do, including some that advertise peptide accounts, and some don’t. It’s a requirement set by individual processors and their banks rather than a published card-network rule, so ask each provider and get the answer in writing.
